The important announcements for Hong Kong stocks today are as follows:
1) Company News
$TENCENT (00700.HK)$The USA Department of Defense mistakenly listed the company as a Chinese Military Industry enterprise and will initiate a review process and take necessary measures. In addition, it spent 1.501 billion HKD to repurchase 3.93 million shares at a repurchase price of 376.8-392.4 HKD.
$CHINA OVERSEAS (00688.HK)$In 2024, the cumulative contract sales reached 310.691 billion yuan, an increase of 0.3% year-on-year; December sales were 40.226 billion yuan, an increase of 76.6% year-on-year.
$GREENTOWN CHINA (03900.HK)$In 2024, the cumulative contract sales amount was approximately 276.8 billion yuan, a decrease of 8.07% year-on-year.
$CH OVS G OCEANS (00081.HK)$In 2024, accumulated contract sales reached 40.11 billion yuan, a year-on-year decrease of 6.3%. Sales in December were 4.584 billion yuan, an increase of 82.6% year-on-year.
$CIFI HOLD GP (00884.HK)$In 2024, accumulated contract sales totaled 33.68 billion yuan, with December sales of 2.4 billion yuan.
$CHINA JINMAO (00817.HK)$In 2024, accumulated contract sales amounted to 98.255 billion yuan.
$COUNTRY GARDEN (02007.HK)$In December 2024, sales were 3.42 billion yuan.
$BRIGHT SMART (01428.HK)$: The consolidated after-tax net profit for the first nine months of the 2024/25 fiscal year is approximately 0.476 billion Hong Kong dollars, an increase of about 8% year-on-year. As of December 31, 2024, the total number of customer accounts reached 0.5791 million.
$DONGFANG ELEC (01072.HK)$: Dongfang Wind Power will sell 51% equity of its subsidiary Mulei Dongxin to ChuanTou New Energy.
$SKB BIO-B (06990.HK)$: The new drug application for the core product Trastuzumab is accepted by the National Medical Products Administration.
$CSPC PHARMA (01093.HK)$: SYS6045 (Antibody-Drug Conjugate) has received approval for clinical trials. This approval is for the indication of advanced solid tumors, expected to be applicable for the treatment of breast cancer, gastric cancer, endometrial cancer, cervical cancer, colorectal cancer, and others.
$ARTS OPTICAL (01120.HK)$Intent to cooperate in the development of smart glasses and optical accessories related to virtual reality.
$SUNSHINE OIL (02012.HK)$An interest waiver agreement has been signed with the holders of the deferred payment.
$ROBOSENSE (02498.HK)$In 2024, the sales volume of Lidar products is expected to be approximately 0.5442 million units.
$BOJUN EDU (01758.HK)$Subscription for no more than 53 million Hong Kong dollars of shares in Yibin Commercial Bank's international offering.
2) Buyback dynamics
$KUAISHOU-W (01024.HK)$: Invested 69.1279 million Hong Kong dollars to repurchase 1.7255 million shares, with a repurchase price of 39.85-40.6 Hong Kong dollars.
$AIA (01299.HK)$: Invested 61.8183 million Hong Kong dollars to repurchase 1.1298 million shares, with a repurchase price of 54.15-55.65 Hong Kong dollars.
$TIMES ELECTRIC (03898.HK)$: Invested 39.3666 million Hong Kong dollars to repurchase 1.2981 million shares, with a repurchase price of 30.05-30.85 Hong Kong dollars.
Editor/Somer
